Abiopharma

🔍 Prince Douglas S (Executive)

Company: Senseonics Holdings, Inc. (SENS)

Report Date: 2026-01-02

Detailed Transactions and Holdings:

• Acquired 1,379 shares of Common Stock at $5.89 per share (Direct)
  Date: 2026-01-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 56,743.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: This common stock was issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $8,122.31 divided by $5.89, the closing price of Issuer's common stock on the Nasdaq Global Select Market on January 2, 2026.
• F2: Effective October 17, 2025, the Issuer effected a 1-for-20 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split.